Anmelden/Registrieren
Erscheinungsjahr:
 
Zurück zur geteilten Ansicht
Jordan U. Gutterman

Veröffentlichungen von Jordan U. Gutterman zu Gutterman, Jordan ->
weitere Veröffentlichungen von Jordan U. Gutterman:
Research Funding: Clinical investigators: The driving force behind drug discovery (1997)
Cancer systemic active immunotherapy today — prospects for tomorrow (1977)
Activation of 2′,5′-oligoadenylate synthetase and B-2 microglobulin in cancer patients treated with partially pure gamma interferon: Dependence of biological effect on administration route (1986)
A phase I trial of recombinant alpha-2a Interferon (Roferon-A) with weekly cisplatinum (1991)
Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions (1977)
Combined modality therapy of malignant melanoma (1979)
BCG immunotherapy for recurrent malignant melanoma (1980)
Evaluation of therapy with methanol extraction residue of BCG (MER) (1982)
Phase II evaluation of interferon added to tamoxifen in the treatment of metastatic breast cancer (1991)
Phase I clinical trial of intralesional or intraventricular leukocyte interferon for intracranial malignancies (1985)
The antineoplastic effect of Corynebacterium parvum modified by lysozyme treatment (1980)
A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia (1987)
Expression of epidermal growth factor receptor and associated glycoprotein on cultured human brain tumor cells (1986)
The need for immune evaluation prior to thymosin-containing chemoimmunotherapy for melanoma (1979)
Its possible application in the management of large-bowel cancer (1974)
Veröffentlichungen zu Gutterman, Jordan
Zurück zur geteilten Ansicht
Verfasser Titel Jahr absteigend sortierenaufsteigend sortieren
zeige Details
1
Gutterman, Jordan U. Research Funding: Clinical investigators: The driving force behind drug discovery
in: Nature biotechnology . - New York, NY : Nature America, ISSN 1546-1696, Vol. 15, No. 7 (1997), p. 598-599
Zugang: zum Volltext
ähnliche Vorschläge
1997
zeige Details
2
Gutterman, Jordan U. Cancer systemic active immunotherapy today — prospects for tomorrow
in: Cancer immunology immunotherapy , ISSN 1432-0851, Vol. 2 (1. 1977), p. 1-9
Zugang: zum Volltext
ähnliche Vorschläge
1977
zeige Details
3
Rosenblum, Michel G., Riso, Adan, ... Activation of 2′,5′-oligoadenylate synthetase and B-2 microglobulin in cancer patients treated with partially pure gamma interferon: Dependence of biological effect on...
in: Cancer chemotherapy and pharmacology , ISSN 1432-0843, Vol. 16 (3. 1986), p. 273-276
Zugang: zum Volltext
ähnliche Vorschläge
1986
zeige Details
4
Hoff, Daniel D., Gutterman, Jordan, ... Activity of human leukocyte interferon in a human tumor cloning system
in: Cancer chemotherapy and pharmacology , ISSN 1432-0843, Vol. 8 (1. 1982), p. 99-103
Zugang: zum Volltext
ähnliche Vorschläge
1982
zeige Details
5
Koff, Wayne C., Fogler, William E., ... Efficient activation of human blood monocytes to a tumoricidal state by liposomes containing human recombinant gamma interferon
in: Cancer immunology immunotherapy , ISSN 1432-0851, Vol. 19 (2. 1985), p. 85-89
Zugang: zum Volltext
ähnliche Vorschläge
1985
zeige Details
6
Dhingra, Kapil, Talpaz, Moshe, ... A phase I trial of recombinant alpha-2a Interferon (Roferon-A) with weekly cisplatinum
in: Investigational new drugs , ISSN 1573-0646, Vol. 9 (1. 1991), p. 37-39
Zugang: zum Volltext
ähnliche Vorschläge
1991
zeige Details
7
Schwarz, Max A., Gutterman, Jordan U., ... Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions
in: World journal of surgery , ISSN 1432-2323, Vol. 1 (5. 1977), p. 555-579
Zugang: zum Volltext
ähnliche Vorschläge
1977
zeige Details
8
Hersh, Evan M., Gutterman, Jordan U., ... Combined modality therapy of malignant melanoma
in: World journal of surgery , ISSN 1432-2323, Vol. 3 (3. 1979), p. 329-339
Zugang: zum Volltext
ähnliche Vorschläge
1979
zeige Details
9
Rasmussen, Shelley L., Gutterman, Jordan U., ... BCG immunotherapy for recurrent malignant melanoma
in: Cancer immunology immunotherapy , ISSN 1432-0851, Vol. 10 (1. 1980), p. 17-26
Zugang: zum Volltext
ähnliche Vorschläge
1980
zeige Details
10
Hersh, Evan M., Quesada, Jorge, ... Evaluation of therapy with methanol extraction residue of BCG (MER)
in: Cancer immunology immunotherapy , ISSN 1432-0851, Vol. 14 (1. 1982), p. 4-9
Zugang: zum Volltext
ähnliche Vorschläge
1982
zeige Details
11
Obbens, Eugenie AMT, Feun, Lynn G, ... Phase I clinical trial of intralesional or intraventricular leukocyte interferon for intracranial malignancies
in: Journal of neuro-oncology , ISSN 1573-7373, Vol. 3 (1. 1985), p. 61-67
Zugang: zum Volltext
ähnliche Vorschläge
1985
zeige Details
12
Macheledt, Janet E., Buzdar, Aman U., ... Phase II evaluation of interferon added to tamoxifen in the treatment of metastatic breast cancer
in: Breast cancer research and treatment , ISSN 1573-7217, Vol. 18 (3. 1991), p. 165-170
Zugang: zum Volltext
ähnliche Vorschläge
1991
zeige Details
13
Hwang, Kou M., Hersh, E. M., ... The antineoplastic effect of Corynebacterium parvum modified by lysozyme treatment
in: Cancer immunology immunotherapy , ISSN 1432-0851, Vol. 8 (2/3. 1980), p. 113-117
Zugang: zum Volltext
ähnliche Vorschläge
1980
zeige Details
14
Kurzrock, Razelle, Shtalrid, Mordechai, ... A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia
in: Nature . - London [u.a.] : Nature Publising Group, ISSN 1476-4687, Vol. 325, No. 6105 (1987), p. 631-635
Zugang: zum Volltext
ähnliche Vorschläge
1987
zeige Details
15
Steck, Peter A.., Gallick, Gary E.., ... Expression of epidermal growth factor receptor and associated glycoprotein on cultured human brain tumor cells
in: Journal of Cellular Biochemistry, in: Journal of Cellular Biochemistry . - New York, N.Y. : Alan R. Liss, Inc, ISSN 0730-2312, ZDB-ID 1479976-5 Vol. 32 (1. 1986), p. 1-10
Zugang: zum Volltext
ähnliche Vorschläge
1986
zeige Details
16
Patt, Yehuda Z., Hersh, Evan M., ... The need for immune evaluation prior to thymosin-containing chemoimmunotherapy for melanoma
in: Cancer immunology immunotherapy , ISSN 1432-0851, Vol. 7 (2. 1979), p. 131-136
Zugang: zum Volltext
ähnliche Vorschläge
1979
zeige Details
17
Mavligit, Giora M., Gutterman, Jordan U., ... Its possible application in the management of large-bowel cancer
in: Digestive diseases and sciences , ISSN 1573-2568, Vol. 19 (11. 1974), p. 1047-1053
Zugang: zum Volltext
ähnliche Vorschläge
1974